Don’t Gamble on Tablet Tooling Maintenance

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology, Trends in Manufacturing, May 2022
Volume 2022 eBook
Issue 2
Pages: 10–15

By following some fundamental steps, manufacturers can optimize their tablet tooling maintenance and resulting productivity.

Tablet tooling maintenance

SPLITOV27 - STOCK.ADOBE.COM

With millions of tablets coming off production lines daily, it is no surprise that tooling can be affected. Consistent compaction of granules into a quality solid dose form is challenging enough for manufacturers without the added concern of the tooling not being up to the job.

The condition of punches and dies will have a substantial impact on productivity, so it is crucial that all tablet tooling is optimized through simple maintenance procedures to enhance performance and improve longevity.

Read this article in Pharmaceutical Technology's May 2022 Trends in Manufacturing eBook.

About the author

Andy Dumelow is head of Technical Sales at I Holland.

Article details

Pharmaceutical Technology
eBook: Trends in Manufacturing
May 2022
Pages: 10–15

Citation

When referring to this article, please cite it as A. Dumelow, “Don’t Gamble on Tablet Tooling Maintenance,” Pharmaceutical Technology's Trends in Manufacturing eBook (May 2022).

Articles in this issue
continuous biomanufacturing
Demonstrating a Fully Continuous Bioprocess
Manufacturing OSD Forms: Key Trends Shaping the Industry
Manufacturing OSD Forms: Key Trends Shaping the Industry
Tablet tooling maintenance
Don’t Gamble on Tablet Tooling Maintenance
Tashatuvango/Stock.adobe.com – The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.
Implementing Continuous Bioprocessing: From Theory to Practice
The Lighthouse Effect: Using Technology to Improve Life Sciences Manufacturing
The Lighthouse Effect: Using Technology to Improve Life Sciences Manufacturing
Plan Early: Optimizing Stability During Lyophilization
Plan Early: Optimizing Stability During Lyophilization
Opportunities for Growth and Breakthroughs for Cell and Gene Therapies
Opportunities for Growth and Breakthroughs for Cell and Gene Therapies
Converting Injectable Therapies to Combination Drug-Device Products
Converting Injectable Therapies to Combination Drug-Device Products
Using Robotics in the Aseptic Manufacturing Facility of the Future
Using Robotics in the Aseptic Manufacturing Facility of the Future
Embracing New Realities
Embracing New Realities
Recent Videos
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Behind the Headlines episode 6
Behind the Headlines episode 5
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Feliza Mirasol
December 20th 2024
Article

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novo Nordisk to Establish New Production Facility for Rare Disease Therapies in Denmark with DKK 8.5 Billion Investment

Feliza Mirasol
December 17th 2024
Article

Novo Nordisk will use the DKK 8.5 billion (US$1.2 billion) to build a new modular and flexible production facility in Odense, Denmark, that will produce multiple products for rare diseases.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Novo Nordisk Gains Manufacturing Sites from Novo Holdings and Novavax while EC Approves Catalent Acquisition

Feliza Mirasol
December 11th 2024
Article

The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.

3D printed pills and drugs, future of medicine. 3D Printing Drugs In Pharmacies. Multi-colored, various drugs, pills, capsules. Pharmaceutical medical concept | Image Credit: © irissca - © irissca - stock.adobe.com

Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications

Gary Ritchie;Sharon Flank
December 10th 2024
Article

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.